PHATHOM PHARMACEUTICALS INC (PHAT) — institutional ownership

169 funds reported holding PHATHOM PHARMACEUTICALS INC in their latest 13F filings, worth $853M in total (CUSIP 71722W107).

Largest holders

1. Frazier Life Sciences Management, L.P. — $135M
2. Medicxi Ventures Management (Jersey) Ltd — $81.0M
3. VANGUARD GROUP INC — $52.7M
4. BlackRock, Inc. (BLK) — $49.1M
5. Invesco Ltd. (IVZ) — $43.7M
6. Carlyle Group Inc. (CG, CGABL) — $37.9M
7. MILLENNIUM MANAGEMENT LLC — $36.6M
8. VANGUARD CAPITAL MANAGEMENT LLC — $28.8M
9. GW&K Investment Management, LLC — $23.5M
10. WASATCH ADVISORS LP — $21.5M

Famous investors holding it

• Izzy Englander portfolio (Millennium Management)
• Ken Griffin portfolio (Citadel Advisors)
• Two Sigma portfolio (Two Sigma Investments)
• Renaissance Technologies portfolio (Renaissance Technologies)
• D. E. Shaw portfolio (D. E. Shaw & Co.)

Insider buying and selling at PHATHOM PHARMACEUTICALS INC

Who owns the most PHAT stock?

The largest institutional holders in the latest 13F filings are Frazier Life Sciences Management, L.P. ($135M), Medicxi Ventures Management (Jersey) Ltd ($81.0M), VANGUARD GROUP INC ($52.7M).

How many funds own PHAT?

169 funds reported holding it, worth $853M in total.